
Residents whose homes survived the wildfires are facing issues with their insurance claims
People whose homes survived the deadly Eaton and Palisades fires are considered the lucky ones while they are surrounded by neighbors who lost everything. Those residents worry their homes may never be safe to live in again.
Some very dangerous materials burned in the fires, things like lithium batteries, asbestos and lead. Residents whose homes survived told KCAL News they don't have a lot of confidence that their insurers will pay to properly clean and de-contaminate their homes.
Even though residents who live near the Eaton Fire burn scar still have their homes, they are now facing issues with their insurance claims.
KCAL News
"You don't really notice it, but then when you wipe it, that's what you're dealing with," said Phil Lindholm, an Altadena resident.
Throughout his home there are remnants of the Eaton Fire that tore through his neighborhood and burned several homes on his street. He said there is ash and soot everywhere and when he walks in, it smells like a campfire.
Kirstin Davis lives right next door to a home that burned, her house is also covered in ash. Davis said that as a parent, it's concerning to have a home full of toxins that could cause health issues.
The Lindholm and Davis families are still waiting on their insurance to send out an adjuster to tell them how and when their homes will be cleaned.
"They don't do environmental or toxicity testing. They don't cover the air, so if the neighborhood air quality is bad, that doesn't matter as long as my structure is cleaned up; that's all they'll do," Davis said.
It's the long-term health risks that have parents like Colin Fisher worried if they can ever move back. He and his wife lived here with their 1-year-old son. His sons' toys and crib are now covered in ash.
"I have no idea if it's toxic, if it's lead. I have a 16-month-old, and I don't want to expose him to lead," Fisher said. "Like if your house burned down, they say they'll take the foundation, the dirt and the ash away, but if your house didn't burn down, my backyard is 10 feet away from a house that will be removed."
Most residents told KCA News they haven't received any claim advancement from their insurance companies. California law only requires those up-front payments for those whose homes are a total loss.
"There are a lot of gray areas, unfortunately, around remediating, you know, fixing smoke damage and restoring a home in a wildfire area that's still standing to a safe and habitable condition," said Amy Bach, with United Policyholders, a consumer advocacy group.
Jason Knedel lived in his childhood home with his wife and elderly mother. The Eaton Fire destroyed the home next door and behind it.
"We aren't going to get back into our house for at least a year, and even if we do, we will have to move out when they start demolishing," Knedel said.
Bach suggests that homeowners who are concerned about the safety of their homes consider hiring their own indoor air quality expert to guide them.
"We hear so many stories about insurance company adjusters who don't have the requisite training, licensure, or experience telling people that their homes are safe to move back into when the homeowners don't really think that's true, and that adjuster has absolutely no qualifications to make that serious a judgment call," Bach said.
While these residents are considered the lucky ones, survivors of the fire feel like their luck has run out and they'll be left for years to pick up the pieces.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Fourth annual Hallie Grace Memorial Butterfly Ball for EB
SAVANNAH, Ga. (WSAV) — Epidermalysis Bullosa, also known as EB, is a rare genetic condition that affects one in every 20,000 births. Babies diagnosed with this condition usually don't live long lives, and they are often referred to as butterfly babies because their skin is as fragile as a butterfly's wings. Turning grief into triumph is how one family, whose child was diagnosed with a rare genetic skin condition, is honoring her life and legacy. 'To be a lost parent is the worst thing in the world. And I would give anything to make sure nobody else has to ever go through that again,' said mother of Hallie Grace and Executive Director of Heroes for Hallie Grace, INC Anne Davis. It's the fourth annual Hallie Grace Memorial Butterfly Ball for EB. Mom of Hallie Grace Anne Davis, who passed away when she was only three months old from the genetic skin condition, said events like these are important to spread awareness because many don't know what EB is or how it affects families dealing with it. 'When you lose a child, the one thing you want more than anything is for them to be remembered and to know that their life mattered,' Davis said. 'So, our biggest mission, is that we raise awareness, we raise funding all that. But our biggest thing is connecting with the families, making sure that those families know that those children still matter, whether or not they're still here.' The painful skin condition is caused by a missing protein that holds the skin together, so with any sort of touch or heat, it can blister the skin and cause it to fall off. Davis said when doctors told her there was nothing they could do; she made it a goal to make sure another family would never have to experience the pain that they felt that day. 'When we get to know these families and we get to see these families go through this and we know what the diagnosis is, it's like watching a Mack truck going to hit someone and not being able to stop it, and so our goal with everything that we do is to stop it,' Davis said. In the three years that Davis and her family have been advocating, there have been medical breakthroughs, now she said they are just waiting for a cure. 'I remember thinking, how do we have nothing,' Davis said. 'Since that time, so in just over a couple of years, we have three approved treatments for EB, two of which could actually work for Hallie's type, depending. But we're getting there. I mean, we're making huge, incredible strides. The FDA has approved these things, so now people don't have to hear there's nothing we can do.' There are only a few tickets left for tonight's ball. If you're interested in purchasing those or just learning more about EB and the heroes for Hallie Grace organization, you can click or tap here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.


Business Upturn
8 hours ago
- Business Upturn
First Ascent Biomedical and Fight Colorectal Cancer Announce Groundbreaking Study to Advance Precision Oncology for Colorectal Cancer Patients
By GlobeNewswire Published on June 6, 2025, 23:41 IST Springfield, Mo., June 06, 2025 (GLOBE NEWSWIRE) — First Ascent Biomedical (FA), an innovative biotech company specializing in transforming cancer treatment through functional precision medicine, is proud to announce a new collaboration with national nonprofit Fight Colorectal Cancer (Fight CRC) to launch a prospective feasibility study aimed at transforming colorectal cancer treatment. Funded by a $350,000 grant from Fight CRC, and spearheaded by Anjee Davis, chief executive officer, this innovative study will leverage First Ascent's cutting-edge xDRIVE tumor profiling technology to deliver rapid, personalized treatment insights for patients fighting colon cancer in Minnesota. 'Fight CRC is committed to empowering patients through innovation,' said Davis. 'This grant underscores our strategic focus on enhancing care through advanced research, particularly for those with limited treatment options.' The study, set to begin enrollment in April or May 2025, will focus on 25 patients with metastatic colorectal cancer. By integrating functional drug testing, genetic analysis, and artificial intelligence, First Ascent's xDRIVE platform will provide oncologists with detailed tumor profiling data and tailored treatment options, aiming to enhance patient outcomes. Leading the clinical efforts are Hao Xie, MD, PhD, a gastrointestinal cancer specialist and precision medicine expert, and Dr. Boardman, whose work in cancer genetics and early detection has advanced the field of colorectal cancer care. Noah Berlow, PhD, First Ascent's Chief Technology Officer and the study's principal investigator, brings his expertise in AI-driven cancer research to oversee the project. Together, this team is poised to demonstrate the power of rapid, individualized tumor profiling to better understand each patient's unique cancer. 'This collaboration with Fight Colorectal Cancer is another important step in transforming how we approach cancer treatment,' said Jim Foote, founder and chief executive officer, First Ascent Biomedical. 'We are honored to be part of this effort.' The study is expected to complete enrollment within nine months and will provide actionable data to oncologists for patients requiring advanced treatment options. Patients interested in participating must be seen in Rochester, MN. Information will soon be available on Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Yahoo
10 hours ago
- Yahoo
First Ascent Biomedical and Fight Colorectal Cancer Announce Groundbreaking Study to Advance Precision Oncology for Colorectal Cancer Patients
Springfield, Mo., June 06, 2025 (GLOBE NEWSWIRE) -- First Ascent Biomedical (FA), an innovative biotech company specializing in transforming cancer treatment through functional precision medicine, is proud to announce a new collaboration with national nonprofit Fight Colorectal Cancer (Fight CRC) to launch a prospective feasibility study aimed at transforming colorectal cancer treatment. Funded by a $350,000 grant from Fight CRC, and spearheaded by Anjee Davis, chief executive officer, this innovative study will leverage First Ascent's cutting-edge xDRIVE tumor profiling technology to deliver rapid, personalized treatment insights for patients fighting colon cancer in Minnesota. 'Fight CRC is committed to empowering patients through innovation,' said Davis. 'This grant underscores our strategic focus on enhancing care through advanced research, particularly for those with limited treatment options.' The study, set to begin enrollment in April or May 2025, will focus on 25 patients with metastatic colorectal cancer. By integrating functional drug testing, genetic analysis, and artificial intelligence, First Ascent's xDRIVE platform will provide oncologists with detailed tumor profiling data and tailored treatment options, aiming to enhance patient outcomes. Leading the clinical efforts are Hao Xie, MD, PhD, a gastrointestinal cancer specialist and precision medicine expert, and Dr. Boardman, whose work in cancer genetics and early detection has advanced the field of colorectal cancer care. Noah Berlow, PhD, First Ascent's Chief Technology Officer and the study's principal investigator, brings his expertise in AI-driven cancer research to oversee the project. Together, this team is poised to demonstrate the power of rapid, individualized tumor profiling to better understand each patient's unique cancer. 'This collaboration with Fight Colorectal Cancer is another important step in transforming how we approach cancer treatment,' said Jim Foote, founder and chief executive officer, First Ascent Biomedical. 'We are honored to be part of this effort.' The study is expected to complete enrollment within nine months and will provide actionable data to oncologists for patients requiring advanced treatment options. Patients interested in participating must be seen in Rochester, MN. Information will soon be available on CONTACT: Savanna Doud Fight Colorectal Cancer 703.548.1225 savanna@ in to access your portfolio